Liquidia Corp (LQDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LQDA | CRSP | DNTH | ||
| Company | Liquidia Corp | Crispr Therapeutics Ag | Dianthus Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 56.00 | 52.83 | 85.36 | ||
| High | 57.80 | 53.81 | 86.11 | ||
| Low | 53.76 | 52.36 | 83.12 | ||
| Latest | 57.59 | 52.75 | 85.74 | ||
| Change | +0.99 | -0.08 | -0.41 | ||
| % Change | +1.75% | -0.15% | -0.48% | ||
| Volume | 2,271,500 | 924,800 | 419,900 | ||
| 20-Day Average Volume | 1,538,345 | 1,800,945 | 469,250 | ||
| Previous Close | 56.60 | 52.83 | 86.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 41.49 | 53.65 | 88.37 | ||
| 20-Day Raw Stochastic | 99.05% | 38.31% | 25.79% | ||
| 20-Day Relative Strength | 80.06 | 50.00 | 52.82 | ||
| Weighted Alpha | +162.53 | +20.90 | +296.80 | ||
| Today's Opinion | 100% Buy | 48% Sell | 80% Buy | ||
| Previous Opinion | 100% Buy | 48% Sell | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.66% since 05/06/26 | -4.23% since 05/06/26 | -5.18% since 05/06/26 | ||
| Low | 39.60 on 05/11/26 | 51.71 on 05/07/26 | 83.12 on 05/13/26 | ||
| High | 57.80 on 05/13/26 | 56.16 on 05/11/26 | 91.24 on 05/07/26 | ||
| 1-Month | |||||
| %Chg | +48.24% since 04/13/26 | -3.79% since 04/13/26 | -4.73% since 04/13/26 | ||
| Low | 35.80 on 04/22/26 | 48.77 on 04/24/26 | 82.00 on 04/29/26 | ||
| High | 57.80 on 05/13/26 | 59.39 on 04/15/26 | 96.50 on 04/16/26 | ||
| 3-Month | |||||
| %Chg | +50.76% since 02/13/26 | -0.60% since 02/13/26 | +80.89% since 02/13/26 | ||
| Low | 29.12 on 02/26/26 | 44.12 on 03/30/26 | 46.80 on 02/19/26 | ||
| High | 57.80 on 05/13/26 | 61.76 on 02/26/26 | 96.50 on 04/16/26 | ||
| 6-Month | |||||
| %Chg | +113.77% since 11/13/25 | +3.21% since 11/13/25 | +141.52% since 11/13/25 | ||
| Low | 26.40 on 11/14/25 | 44.12 on 03/30/26 | 34.29 on 11/14/25 | ||
| High | 57.80 on 05/13/26 | 61.76 on 02/26/26 | 96.50 on 04/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,031,400 | 5,095,401 | 4,709,476 | ||
| Shares Outstanding, K | 88,894 | 96,449 | 54,666 | ||
| Annual Sales | 158,320,000 | 3,510,000 | 2,040,000 | ||
| Annual Net Income | -68,920,000 | -581,600,000 | -162,340,000 | ||
| Last Quarter Sales | 92,020,000 | 1,460,000 | 460,000 | ||
| Last Quarter Net Income | 14,550,000 | -122,930,000 | -40,830,000 | ||
| 60-Month Beta | 0.41 | 1.74 | 1.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.52 on 05/11/26 | -1.28 on 05/04/26 | -0.85 on 05/05/26 | ||
| Earnings Date | 08/11/26 | 08/03/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 379.50 | 0.00 | 0.00 | ||